Cipher Pharmaceuticals

(OTC) CPHRF

Current Price$13.20

Market Cap$333.71M

Since IPO (2012)+905%

5 Year+1,122%

1 Year+29%

1 Month+1%

Cipher Pharmaceuticals Financials at a Glance

Market Cap

$333.71M

Revenue (TTM)

$50.64M

Net Income (TTM)

$27.53M

EPS (TTM)

$1.05

P/E Ratio

12.30

Dividend

$0.00

Beta (Volatility)

0.80 (Low)

Dividend

$0.00

Beta (Volatility)

0.80 (Low)

Price

$13.20

Volume

2,812

Open

$13.20

Price

$13.20

Volume

2,812

Open

$13.20

Previous Close

$13.20

Daily Range

$13.20 - $13.20

52-Week Range

$8.54 - $14.17

Dividend

$0.00

Beta (Volatility)

0.80 (Low)

Price

$13.20

Volume

2,812

Open

$13.20

Previous Close

$13.20

Daily Range

$13.20 - $13.20

52-Week Range

$8.54 - $14.17

CPHRF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cipher Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Craig Mull

Website

www.cipherpharma.com

Headquarters

Mississauga, ON L6H 0M2, CA

CPHRF Financials

Key Financial Metrics (TTM)

Gross Margin

77%

Operating Margin

33%

Net Income Margin

54%

Return on Equity

24%

Return on Capital

13%

Return on Assets

18%

Earnings Yield

8.13%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$333.71M

Shares Outstanding

25.28M

Volume

2.81K

Avg. Volume

5.05K

Financials (TTM)

Gross Profit

$33.77M

Operating Income

$16.80M

EBITDA

$16.80M

Operating Cash Flow

$30.25M

Capital Expenditure

$28.49K

Free Cash Flow

$30.22M

Cash & ST Invst.

$7.48M

Total Debt

$5.49M

Cipher Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$12.41M

+4.9%

Gross Profit

$8.23M

+23.0%

Gross Margin

66.36%

N/A

Market Cap

$333.71M

N/A

Market Cap/Employee

$55.62M

N/A

Employees

N/A

Net Income

$13.52M

+304.2%

EBITDA

$4.27M

+155.3%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$1.98M

+108.7%

Accounts Receivable

$11.19M

-19.3%

Inventory

$8.18M

+41.1%

Long Term Debt

$5.21M

-87.1%

Short Term Debt

$288.47K

-49.0%

Return on Assets

17.63%

N/A

Return on Invested Capital

12.73%

N/A

Free Cash Flow

$8.84M

-0.4%

Operating Cash Flow

$8.87M

-0.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AONCAmerican Oncology Network, Inc.

AONCAmerican Oncology Network, Inc.$9.25+2.78%

NIKANika Pharmaceuticals Inc.

NIKANika Pharmaceuticals Inc.$0.40+0.00%

ABTIAlterola Biotech, Inc.

ABTIAlterola Biotech, Inc.$0.01+0.00%

PSIQProfile Solutions, Inc.

PSIQProfile Solutions, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

NIONio

NIONio$5.91-0.08%

SGOViShares Trust - iShares 0-3 Month Treasury Bond ETF

SGOViShares Trust - iShares 0-3 Month Treasury Bond ETF$100.41+0.00%

AALAmerican Airlines Group

AALAmerican Airlines Group$11.84+0.01%

Questions About CPHRF

What is the current price of Cipher Pharmaceuticals?

Cipher Pharmaceuticals is trading at $13.20 per share.

What is the 52-week range for Cipher Pharmaceuticals?

Over the past 52 weeks, Cipher Pharmaceuticals has traded between $8.54 and $14.17.

How much debt does Cipher Pharmaceuticals have?

As of the most recent reporting period, Cipher Pharmaceuticals reported total debt of $5.50M.

How much cash does Cipher Pharmaceuticals have on hand?

Cipher Pharmaceuticals reported $7.49M in cash and cash equivalents in its most recent financial results.

What is Cipher Pharmaceuticals’s dividend yield?

Cipher Pharmaceuticals does not currently have a dividend yield.

Cipher Pharmaceuticals

Cipher Pharmaceuticals Financials at a Glance

CPHRF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cipher Pharmaceuticals

CPHRF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cipher Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CPHRF

What is the current price of Cipher Pharmaceuticals?

What is the 52-week range for Cipher Pharmaceuticals?

How much debt does Cipher Pharmaceuticals have?

How much cash does Cipher Pharmaceuticals have on hand?

What is Cipher Pharmaceuticals’s dividend yield?

Premium Investing Services